Acepodia's Approach To ACC a CAR Manufacturing Scalability
Acepodia CEO, President, a Co-founder Dr. Sonny Hsiao and Dr. Mark Gilbert, VP of RaD, join Erin Harris and Matt Pillar for a discussion on the company's approach to dramatically reducing the cost of cell therapy development, manufacturing, and administration via its oNK, CAR, and ACC candidates.
